Javier Frontiñán-Rubio

1.0k total citations · 1 hit paper
25 papers, 734 citations indexed

About

Javier Frontiñán-Rubio is a scholar working on Molecular Biology, Physiology and Biomedical Engineering. According to data from OpenAlex, Javier Frontiñán-Rubio has authored 25 papers receiving a total of 734 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Physiology and 10 papers in Biomedical Engineering. Recurrent topics in Javier Frontiñán-Rubio's work include Graphene and Nanomaterials Applications (10 papers), Alzheimer's disease research and treatments (9 papers) and Carbon and Quantum Dots Applications (7 papers). Javier Frontiñán-Rubio is often cited by papers focused on Graphene and Nanomaterials Applications (10 papers), Alzheimer's disease research and treatments (9 papers) and Carbon and Quantum Dots Applications (7 papers). Javier Frontiñán-Rubio collaborates with scholars based in Spain, United States and Italy. Javier Frontiñán-Rubio's co-authors include Mario Durán‐Prado, Ester Vázquez, Francisco J. Alcaı́n, Juan R. Peinado, José M. González‐Domínguez, Viviana Jehová González, M. Victoria Gómez, Cristina Martín, Yoana Rabanal‐Ruiz and Sonia García‐Carpintero and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Javier Frontiñán-Rubio

25 papers receiving 723 citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases

2022 145 citations Rosalía Fernández‐Calle, Sabine C Konings et al. Molecular Neurodegeneration profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Javier Frontiñán-Rubio Spain	14	246	229	205	204	91	25	734
Tian Xie China	10	282 1.1×	225 1.0×	223 1.1×	133 0.7×	65 0.7×	28	940
Jiaying Wu China	18	449 1.8×	204 0.9×	111 0.5×	191 0.9×	143 1.6×	45	1.1k
Jing Di United States	14	334 1.4×	193 0.8×	267 1.3×	216 1.1×	64 0.7×	41	924
Iulia Ioana Lungu Romania	9	302 1.2×	133 0.6×	146 0.7×	114 0.6×	113 1.2×	17	938
Alessia Lasorsa Netherlands	12	308 1.3×	119 0.5×	281 1.4×	143 0.7×	62 0.7×	29	950
Ping Luan China	17	260 1.1×	208 0.9×	169 0.8×	188 0.9×	104 1.1×	47	970
Chenhui Ji China	20	331 1.3×	265 1.2×	103 0.5×	175 0.9×	144 1.6×	32	1.1k
Yanling Zhang China	18	683 2.8×	90 0.4×	118 0.6×	96 0.5×	40 0.4×	56	1.2k
Ambuja Navalkar India	15	357 1.5×	86 0.4×	170 0.8×	71 0.3×	34 0.4×	28	750
Jiehua Xu China	18	841 3.4×	176 0.8×	218 1.1×	106 0.5×	102 1.1×	33	1.4k

Countries citing papers authored by Javier Frontiñán-Rubio

Since Specialization

Citations

This map shows the geographic impact of Javier Frontiñán-Rubio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier Frontiñán-Rubio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier Frontiñán-Rubio more than expected).

Fields of papers citing papers by Javier Frontiñán-Rubio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier Frontiñán-Rubio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier Frontiñán-Rubio. The network helps show where Javier Frontiñán-Rubio may publish in the future.

Co-authorship network of co-authors of Javier Frontiñán-Rubio

This figure shows the co-authorship network connecting the top 25 collaborators of Javier Frontiñán-Rubio. A scholar is included among the top collaborators of Javier Frontiñán-Rubio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier Frontiñán-Rubio. Javier Frontiñán-Rubio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rabanal‐Ruiz, Yoana, Luis Sánchez Rodríguez, Alicia Flores‐Cuadrado, et al.. (2024). Differential accumulation of human β-amyloid and tau from enriched extracts in neuronal and endothelial cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(5). 167204–167204. 1 indexed citations

Llanos-González, Emilio, Javier Frontiñán-Rubio, Yoana Rabanal‐Ruiz, et al.. (2023). Spatial and Temporal Protein Modules Signatures Associated with Alzheimer Disease in 3xTg-AD Mice Are Restored by Early Ubiquinol Supplementation. Antioxidants. 12(3). 747–747. 3 indexed citations

García‐Carpintero, Sonia, et al.. (2023). Screening the micronucleus assay for reliable estimation of the genotoxicity of graphene and other 2D materials. Carbon. 215. 118426–118426. 6 indexed citations

Frontiñán-Rubio, Javier, Sonia García‐Carpintero, Viviana Jehová González, Ester Vázquez, & Mario Durán‐Prado. (2023). Assessment of genotoxicity induced by subchronic exposure to graphene in HaCaT human skin cell line. Nanotoxicology. 17(1). 42–61. 2 indexed citations

González, Viviana Jehová, Javier Frontiñán-Rubio, M. Victoria Gómez, et al.. (2022). Easy and Versatile Synthesis of Bulk Quantities of Highly Enriched ¹³C-Graphene Materials for Biological and Safety Applications. ACS Nano. 17(1). 606–620. 6 indexed citations

Frontiñán-Rubio, Javier, Emilio Llanos-González, Sonia García‐Carpintero, et al.. (2022). CoQ10 reduces glioblastoma growth and infiltration through proteome remodeling and inhibition of angiogenesis and inflammation. Cellular Oncology. 46(1). 65–77. 6 indexed citations

Frontiñán-Rubio, Javier, Viviana Jehová González, Ester Vázquez, & Mario Durán‐Prado. (2022). Rapid and efficient testing of the toxicity of graphene-related materials in primary human lung cells. Scientific Reports. 12(1). 7664–7664. 18 indexed citations

González‐Domínguez, José M., Laura Grasa, Javier Frontiñán-Rubio, et al.. (2022). Intrinsic and selective activity of functionalized carbon nanotube/nanocellulose platforms against colon cancer cells. Colloids and Surfaces B Biointerfaces. 212. 112363–112363. 33 indexed citations

Fernández‐Calle, Rosalía, Sabine C Konings, Javier Frontiñán-Rubio, et al.. (2022). APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases. Molecular Neurodegeneration. 17(1). 62–62. 145 indexed citations breakdown →

10.

Frontiñán-Rubio, Javier, Yoana Rabanal‐Ruiz, Mario Durán‐Prado, & Francisco J. Alcaı́n. (2021). The Protective Effect of Ubiquinone against the Amyloid Peptide in Endothelial Cells Is Isoprenoid Chain Length-Dependent. Antioxidants. 10(11). 1806–1806. 9 indexed citations

11.

Frontiñán-Rubio, Javier, et al.. (2021). Biological Significance of the Protein Changes Occurring in the Cerebrospinal Fluid of Alzheimer’s Disease Patients: Getting Clues from Proteomic Studies. Diagnostics. 11(9). 1655–1655. 6 indexed citations

12.

García‐Carpintero, Sonia, Javier Frontiñán-Rubio, Mariano Amo‐Salas, et al.. (2021). Ubiquinol Supplementation Improves Gender-Dependent Cerebral Vasoreactivity and Ameliorates Chronic Inflammation and Endothelial Dysfunction in Patients with Mild Cognitive Impairment. Antioxidants. 10(2). 143–143. 8 indexed citations

13.

Llanos-González, Emilio, Sonia García‐Carpintero, Javier Frontiñán-Rubio, et al.. (2020). Interplay Between Mitochondrial Oxidative Disorders and Proteostasis in Alzheimer’s Disease. Frontiers in Neuroscience. 13. 1444–1444. 66 indexed citations

14.

García‐Carpintero, Sonia, Javier Frontiñán-Rubio, Emilio Llanos-González, et al.. (2020). A comprehensive systematic review of CSF proteins and peptides that define Alzheimer’s disease. Clinical Proteomics. 17(1). 21–21. 42 indexed citations

15.

Flores‐Cuadrado, Alicia, Daniel Saiz‐Sánchez, Isabel Úbeda‐Bañón, et al.. (2019). Human amyloid-β enriched extracts: evaluation of in vitro and in vivo internalization and molecular characterization. Alzheimer s Research & Therapy. 11(1). 56–56. 18 indexed citations

16.

Frontiñán-Rubio, Javier, Juan R. Peinado, Frank M. LaFerla, et al.. (2018). Sex-dependent co-occurrence of hypoxia and β-amyloid plaques in hippocampus and entorhinal cortex is reversed by long-term treatment with ubiquinol and ascorbic acid in the 3 × Tg-AD mouse model of Alzheimer's disease. Molecular and Cellular Neuroscience. 92. 67–81. 18 indexed citations

17.

Frontiñán-Rubio, Javier, M. Victoria Gómez, Cristina Martín, et al.. (2018). Differential effects of graphene materials on the metabolism and function of human skin cells. Nanoscale. 10(24). 11604–11615. 44 indexed citations

18.

González, Viviana Jehová, Antonio M. Rodríguez, Verónica León, et al.. (2018). Sweet graphene: exfoliation of graphite and preparation of glucose-graphene cocrystals through mechanochemical treatments. Green Chemistry. 20(15). 3581–3592. 57 indexed citations

19.

Pelin, Marco, Laura Fusco, Cristina Martín, et al.. (2018). Graphene and graphene oxide induce ROS production in human HaCaT skin keratinocytes: the role of xanthine oxidase and NADH dehydrogenase. Nanoscale. 10(25). 11820–11830. 101 indexed citations

20.

Torres–Lista, Virginia, Cristina Parrado‐Fernández, Javier Frontiñán-Rubio, et al.. (2014). Neophobia, NQO1 and SIRT1 as premorbid and prodromal indicators of AD in 3xTg-AD mice. Behavioural Brain Research. 271. 140–146. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact